NVAX Novavax
WatchlistNovavax News
This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
On CNBC's "Mad Money Lightning Round," Jim Cramer said Camtek Ltd. (NASDAQ:CAMT) is a "fabulous" company, but the stock is "too expensive." He recommended waiting for a pullback. Cramer said he di
Cramer's Lightning Round: 'Nothing Good to Say' About Novavax
It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.
Novavax Shares Dip Tuesday as Market Sees Mixed Results
Express News | Novavax Says Updated COVID-19 Vaccine Now Authorized In Canada
Is Novavax Stock a Buy Now?
Market Chatter: South Korea Grants Emergency Authorization for Updated Novavax Covid-19 Vaccine
South Korea will have access to an upgraded Covid-19 vaccine produced by the US-based biotech company Novavax (NVV1.F), which has obtained approval in the US and Europe, Pulse News reported Thursday.
'Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization In The Republic Of Korea' - Novavax
'Novavax's Updated COVID-19 Vaccine Receives Emergency Use Authorization In The Republic Of Korea' - Novavax
Novavax's (NVAX) Updated COVID Jab Gets WHO Nod for Emergency Use
Les 194 États Membres De L'Organisation Mondiale De La Santé Ont Désormais La Possibilité D'utiliser Le Vaccin COVID-19 À Base De Protéines Mis À Jour Par Novavax
GAITHERSBURG, Maryland, 29 novembre 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), une entreprise mondiale œuvrant pour l'avancement des vaccins à base de protéines avec son adjuvant Matrix-M,
Novavax's COVID-19 Vaccine Nuvaxovid to Become Unavailable in Singapore From January 2024
Novavax's (NVAX) COVID-19 vaccine Nuvaxovid will no longer be available under Singapore's national vaccination programme from Jan. 1, 2024, as supply has stopped while the existing local stock will ex
Street Color: Novavax's COVID-19 Vaccine Not Available Under Singapore's National Vaccination Programme, Starting Jan. 1
(Street Color news is derived from real time discussions with market professionals globally subscribed to the Street Color Premium Chat service on Bloomberg IB Chat and the ICE IM. This information is
La Vacuna COVID-19 De Novavax Ahora Es Una Opción Para Los 194 Estados Miembros De La OMS
-La vacuna COVID-19 actualizada a base de proteínas de Novavax ahora es una opción para los 194 estados miembros de la Organización Mundial de la Salud GAITHERSBURG, Md., 28 de noviembre de 2023
Novavax Gains WHO Emergency Use Listing for COVID-19 Vaccine
Novavax's (NVV1.F) COVID-19 vaccine Nuvaxovid secured emergency use listing from the World Health Organization, or WHO, for active immunization for ages 12 and older against the disease.
What's Going On With Novavax Stock Tuesday?
Novavax Inc (NASDAQ:NVAX) shares are trading higher Tuesday. The company announced that its protein-based Covid-19 vaccine received Emergency Use Listing (EUL). What Happened: The World Health Organiz
WHO Grants EUL For Novavax's Updated Protein-based COVID-19 Vaccine
Express News | Novavax's Nuvaxovid XBB.1.5 COVID-19 Vaccine Has Been Granted Emergency Use Listing By The World Health Organization For Active Immunization In Individuals Aged 12 And Older
Novavax's Updated Protein-based COVID-19 Vaccine Now an Option for All 194 Member States of the World Health Organization
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that Nuvaxovid XBB.1.5...
Novavax Updates Leadership Structure, Names COO
Express News | Novavax Hires John Trizzino As The President And Chief Operating Officer (Newly Created Roles); Company's Current Chief Legal Officer and Corporate Secretary John Herrmann Will Retire Effective December 8; Mark Casey To Join As Herrmann's Successor
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced changes to its executive ...